Los Angeles Business Journal

Mallinckrodt to Buy Questcor

Monday, April 7, 2014

Mallinckrodt is buying Anaheim Hills' Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business, the Associated Press reports.